Online first
Original paper
Published online: 2024-08-26

open access

Page views 137
Article views/downloads 85
Get Citation

Connect on Social Media

Connect on Social Media

Nootkatone mitigates periodontal inflammation and reduces alveolar bone loss via Nrf2/HO-1 and NF-κB pathways in rat model of periodontitis

Ye Yin1, Zeyu Ma1, Peiliang Shi1

Abstract

Introduction. Periodontitis (PD) is a chronic inflammatory disease leading to alveolar bone loss. This study investigates the effect of nootkatone and regulatory mechanism in reducing periodontal inflammation and alveolar bone loss in a rat model.

Material and methods. Twenty male Sprague-Dawley rats were divided into control, periodontitis, and nootkatone-treated groups (45 or 90 mg/kg). Ligature induction method was adopted to establish the PD model. After 21 days, rats received daily gavage of either saline or nootkatone for 10 days. Alveolar bone loss was assessed using micro-CT. Histological analyses included hematoxylin and eosin (H&E), tartrate-resistant acid phosphatase (TRAP), and Masson’s trichrome stainings. Immunohistochemistry for heme oxygenase 1 (HO-1) and nuclear factor erythroid-2 related factor 2 (Nrf2) were performed in periodontal tissues. Content of inflammatory cytokines IL-1β, IL-6, and TNF-α in gingival tissues around ligature were assessed using ELISA kits. Malondialdehyde (MDA) level and superoxide dismutase (SOD) activity were analyzed and Western blot for NF-κB expression in gingival tissues were performed.

Results. Nootkatone significantly reduced the distance from cementoenamel junction to alveolar bone crest (CEJ-ABC), enhanced bone mineral density (BMD), bone volume (BV), and BV/total volume (TV) ratio in ligature-induced rats. Higher dose of nootkatone (90 mg/kg) did not show more significant therapeutic effect than lower dose (45 mg/kg). Histological staining showed decreased osteoclasts’ number and improved bone architecture in the nootkatone group. Content of IL-1β, IL-6, and TNF-α and inflammatory cell infiltration level in gingival tissues around the ligature were decreased by the nootkatone-treatment rats. Nootkatone increased Nrf2 and HO-1 protein expression and decreased NF-κB protein level, suppressing MDA levels and enhancing SOD activity.

Conclusions. In a rat model, nootkatone effectively mitigates periodontal inflammation and alveolar bone loss through the Nrf2/HO-1 and NF-κB pathways. These findings suggest nootkatone as a promising therapeutic agent for the treatment of periodontitis.

Article available in PDF format

View PDF Download PDF file

References

  1. Li S, Yang W, Li A, et al. Protective effect of Nrf2 in periodontitis — a preclinical systematic review and meta-analysis. Arch Oral Biol. 2023; 151: 105713.
  2. Pihlstrom BL, Michalowicz BS, Johnson NW. Periodontal diseases. Lancet. 2005; 366(9499): 1809–1820.
  3. Fang L, Zhang Y, Cheng L, et al. Silica nanoparticles containing nano-silver and chlorhexidine to suppress biofilm and modulate multispecies biofilms toward healthy tendency. J Oral Microbiol. 2024; 16(1): 2361403.
  4. Kinane D, Stathopoulou P, Papapanou P. Periodontal diseases. Nat Rev Dis Primers. 2017; 3(1): 17038.
  5. Kitaura H, Kimura K, Ishida M, et al. Immunological reaction in TNF-α-mediated osteoclast formation and bone resorption in vitro and in vivo. Clin Dev Immunol. 2013; 2013: 181849.
  6. Jakovljevic A, Knezevic A, Karalic D, et al. Pro-inflammatory cytokine levels in human apical periodontitis: correlation with clinical and histological findings. Aust Endod J. 2015; 41(2): 72–77.
  7. Guarnieri R, Reda R, Di Nardo D, et al. Expression of IL-1β, IL-6, TNF-α, and a-MMP-8 in sites with healthy conditions and with periodontal and peri-implant diseases: A case-control study. J Dent Res Dent Clin Dent Prospects. 2024; 18(2): 135–142.
  8. Wei W, Li J, Liu X, et al. Inhibition of RGS10 aggravates periapical periodontitis via upregulation of the NF-κB pathway. J Endod. 2022; 48(10): 1308–1318.e5.
  9. Wei J, Xu S, Zhou X, et al. Research progress in the molecular regulatory mechanisms of alveolar bone restoration. Sichuan Da Xue Xue Bao Yi Xue Ban. 2024; 55(1): 31–38.
  10. Juiz PJ, Ferreira LT, Pires EA, et al. Patent mining on the use of antioxidant phytochemicals in the technological development for the prevention and treatment of periodontitis. Antioxidants (Basel). 2024; 13(5).
  11. Yetkin Ay Z, Bakır B, Bozkurt ŞB, et al. Positive effect of curcumin on experimental peridontitis via suppression of IL-1-beta and IL-6 expression level. Int J Vitam Nutr Res. 2022; 92(3-4): 231–239.
  12. Xiao CJ, Yu XJ, Xie JL, et al. Protective effect and related mechanisms of curcumin in rat experimental periodontitis. Head Face Med. 2018; 14(1): 12.
  13. Justo MP, Cardoso Cd, Cantiga-Silva C, et al. Curcumin reduces inflammation in rat apical periodontitis. Int Endod J. 2022; 55(11): 1241–1251.
  14. Bhattarai G, Poudel SB, Kook SH, et al. Resveratrol prevents alveolar bone loss in an experimental rat model of periodontitis. Acta Biomater. 2016; 29: 398–408.
  15. Fan Q, Zhou XH, Wang TF, et al. Effects of epigallocatechin-3-gallate on oxidative stress, inflammation, and bone loss in a rat periodontitis model. J Dent Sci. 2023; 18(4): 1567–1575.
  16. Cankar K, van Houwelingen A, Goedbloed M, et al. Valencene oxidase CYP706M1 from Alaska cedar (Callitropsis nootkatensis). FEBS Lett. 2014; 588(6): 1001–1007.
  17. Habotta OA, Abdeen A, Roomi AB, et al. Nootkatone mitigated melamine-evoked hepatotoxicity by featuring oxidative stress and inflammation interconnected mechanisms: in vivo and in silico approaches. Toxics. 2023; 11(9).
  18. Meeran MF, Azimullah S, Adeghate E, et al. Nootkatone attenuates myocardial oxidative damage, inflammation, and apoptosis in isoproterenol-induced myocardial infarction in rats. Phytomedicine. 2021; 84: 153405.
  19. Park JE, Leem YH, Park JS, et al. Astrocytic Nrf2 mediates the neuroprotective and anti-inflammatory effects of nootkatone in an MPTP-induced Parkinson's disease mouse model. Antioxidants (Basel). 2023; 12(11).
  20. Habotta OA, Abdeen A, El-Hanafy AA, et al. Sesquiterpene nootkatone counteracted the melamine-induced neurotoxicity via repressing of oxidative stress, inflammatory, and apoptotic trajectories. Biomed Pharmacother. 2023; 165: 115133.
  21. Xu Y, Zhang M, Yang W, et al. Nootkatone protects cartilage against degeneration in mice by inhibiting NF-κB signaling pathway. Int Immunopharmacol. 2021; 100: 108119.
  22. Graves DT, Kang J, Andriankaja O, et al. Animal models to study host-bacteria interactions involved in periodontitis. Front Oral Biol. 2012; 15: 117–132.
  23. Borges JS, Costa VC, Irie MS, et al. Definition of the region of interest for the assessment of alveolar bone repair using micro-computed tomography. J Digit Imaging. 2023; 36(1): 356–364.
  24. Ding Z, Wang A, Liu Y, et al. Physiological occlusal force attenuates replacement root resorption of replanted teeth: an experimental animal study. BMC Oral Health. 2024; 24(1): 658.
  25. Na KH, Lee HJ, Lee JE, et al. Regeneration of rabbit calvarial defects with combination of stem cells and enamel matrix derivative: a microcomputed tomography and histological evaluation comparing two- and three-dimensional cell constructs. Medicina (Kaunas). 2024; 60(3).
  26. Wu H, Kong Y, Zhao W, et al. Measurement of cellular MDA content through MTBE-extraction based TBA assay by eliminating cellular interferences. J Pharm Biomed Anal. 2024; 248: 116332.
  27. Dai C, Liu M, Zhang Q, et al. Nootkatone supplementation attenuates carbon tetrachloride exposure-induced nephrotoxicity in mice. Antioxidants (Basel). 2023; 12(2).
  28. Dai C, Zhang X, Lin J, et al. Nootkatone supplementation ameliorates carbon tetrachloride-induced acute liver injury via the inhibition of oxidative stress, Nf-κB pathways, and the activation of Nrf2/HO-1 pathway. Antioxidants (Basel). 2023; 12(1).
  29. Al-Salam S, Kandhan K, Sudhadevi M, et al. Nootkatone ameliorates doxorubicin induced myocardial injury through modulation of NF-κB sgnals and oxidative stress. Cell Physiol Biochem. 2022; 56(4): 401–417.
  30. Zhang Q, Liu J, Duan H, et al. Activation of Nrf2/HO-1 signaling: an important molecular mechanism of herbal medicine in the treatment of atherosclerosis the protection of vascular endothelial cells from oxidative stress. J Adv Res. 2021; 34: 43–63.
  31. Wang J, Behl T, Rana T, et al. Exploring the pathophysiological influence of heme oxygenase-1 on neuroinflammation and depression: a study of phytotherapeutic-based modulation. Phytomedicine. 2024; 127: 155466.
  32. Zafar S, Luo Y, Zhang Li, et al. Daidzein attenuated paclitaxel-induced neuropathic pain via the down-regulation of TRPV1/P2Y and up-regulation of Nrf2/HO-1 signaling. Inflammopharmacology. 2023; 31(4): 1977–1992.
  33. Au WH, Miller-Fleming L, Sanchez-Martinez A, et al. Activation of the Keap1/Nrf2 pathway suppresses mitochondrial dysfunction, oxidative stress, and motor phenotypes in ALS/FTD models. Life Sci Alliance. 2024; 7(9).
  34. Loboda A, Damulewicz M, Pyza E, et al. Role of Nrf2/HO-1 system in development, oxidative stress response and diseases: an evolutionarily conserved mechanism. Cell Mol Life Sci. 2016; 73(17): 3221–3247.
  35. Yuan Z, Li J, Xiao F, et al. Sinensetin protects against periodontitis through binding to Bach1 enhancing its ubiquitination degradation and improving oxidative stress. Int J Oral Sci. 2024; 16(1): 38.
  36. Wang J, Chen Y, Yuan H, et al. Mitochondrial biogenesis disorder and oxidative damage promote refractory apical periodontitis in rat and human. Int Endod J. 2024; 57(9): 1326–1342.
  37. Lee HY, Lee GH, Kim JH, et al. Ixeris dentata and Lactobacillus gasseri media protect against periodontitis through Nrf2-HO-1 signalling pathway. Sci Rep. 2023; 13(1): 12861.
  38. Wenjing S, Mengmeng L, Lingling S, et al. Galectin-3 inhibition alleviated LPS-induced periodontal inflammation in gingival fibroblasts and experimental periodontitis mice. Clin Sci (Lond). 2024; 138(12): 725–739.
  39. Graves DT, Li J, Cochran DL. Inflammation and uncoupling as mechanisms of periodontal bone loss. J Dent Res. 2011; 90(2): 143–153.
  40. Krutyhołowa A, Strzelec K, Dziedzic A, et al. Host and bacterial factors linking periodontitis and rheumatoid arthritis. Front Immunol. 2022; 13: 980805.
  41. Apolinário Vieira GH, Aparecida Rivas AC, Figueiredo Costa K, et al. Specific inhibition of IL-6 receptor attenuates inflammatory bone loss in experimental periodontitis. J Periodontol. 2021; 92(10): 1460–1469.
  42. Sánchez GA, Miozza VA, Delgado A, et al. Salivary IL-1β and PGE2 as biomarkers of periodontal status, before and after periodontal treatment. J Clin Periodontol. 2013; 40(12): 1112–1117.
  43. Relvas M, Mendes-Frias A, Gonçalves M, et al. Salivary IL-1β, IL-6, and IL-10 Are Key Biomarkers of Periodontitis Severity. Int J Mol Sci. 2024; 25(15).
  44. Delima AJ, Oates T, Assuma R, et al. Soluble antagonists to interleukin-1 (IL-1) and tumor necrosis factor (TNF) inhibits loss of tissue attachment in experimental periodontitis. J Clin Periodontol. 2001; 28(3): 233–240.
  45. Liu C, Chen Y, Bai H, et al. Characterization and application of in situ curcumin/ZNP hydrogels for periodontitis treatment. BMC Oral Health. 2024; 24(1): 395.
  46. Ding Xu, Hou Y, Liu X, et al. The role of Sirt3-induced autophagy in renal structural damage caused by periodontitis in rats. J Periodontal Res. 2023; 58(1): 97–108.
  47. Corrêa MG, Absy S, Tenenbaum H, et al. Resveratrol attenuates oxidative stress during experimental periodontitis in rats exposed to cigarette smoke inhalation. J Periodontal Res. 2019; 54(3): 225–232.
  48. Batool F, Morand DN, Thomas L, et al. Synthesis of a novel electrospun polycaprolactone scaffold functionalized with ibuprofen for periodontal regeneration: an in vitro and in vivo study. Materials (Basel). 2018; 11(4).
  49. Yang M, Shrestha SK, Soh Y, et al. Effects of aloe-emodin on alveolar bone in -induced periodontitis rat model: a pilot study. J Periodontal Implant Sci. 2022; 52(5): 383–393.